Work

Figure S2 from Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription

Year: 2023

Type: other

Abstract: Supplementary Figure 2: Downregulation of MYC and MCL1 is detected in the whole blood of Enitociclib-treated DH-DLBCL as well as other MYC+ NHL patients

DOI: 10.1158/2767-9764.24534399.v1

Authors: Melanie M. Frigault, Arushi Mithal, Harvey Wong, Beatrix Stelte-Ludwig, Vinay Mandava, Xin Huang, Joseph Birkett, Amy J. Johnson, Raquel Izumi, Ahmed Hamdy

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4388525919

Cites:

Cited by:

Related to: 10